We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Musculoskeletal Outcomes After Bone Marrow Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00558948
Recruitment Status : Completed
First Posted : November 16, 2007
Last Update Posted : August 19, 2009
Information provided by:
Sidney Kimmel Comprehensive Cancer Center

Brief Summary:
The purpose of the study is to evaluate bone mineral density and muscle strength in survivors of bone marrow transplant. Association with age, type of transplant, steroids, years since transplant, body composition, endocrinopathies, radiation, quality of life and physical activity will be explored.

Condition or disease
Survivors of Bone Marrow Transplant Autologous and Allogeneic

Detailed Description:
Bone marrow transplant survivors are at risk of diminished bone mineral density. Mechanisms and risks are not well understood. This study will help identify risks factors for developing this complication.

Study Type : Observational
Actual Enrollment : 48 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Musculoskeletal Outcomes After Bone Marrow Transplant
Study Start Date : May 2007
Primary Completion Date : August 2009
Study Completion Date : August 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   8 Years to 30 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Survivors of bone marrow transplant (autologous and allogeneic) who are at least 1 year from transplant.

Inclusion Criteria:

  • Ages 8-30 years
  • One year from transplant

Exclusion Criteria:

  • No current steroid use
  • Medical conditions that would prohibit testing
  • Neuropsychological conditions that prohibit completing questionnaires

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00558948

United States, Maryland
Johns Hopkins University, Bayview Campus
Baltimore, Maryland, United States, 21212
Sponsors and Collaborators
Sidney Kimmel Comprehensive Cancer Center
Study Director: Kathy Ruble, PhDc, RN Johns Hopkins University, School of Nursing

Responsible Party: Kathy Ruble, PhDc, RN, SKCCC
ClinicalTrials.gov Identifier: NCT00558948     History of Changes
Other Study ID Numbers: J06120
1F31NR010038-01 ( U.S. NIH Grant/Contract )
First Posted: November 16, 2007    Key Record Dates
Last Update Posted: August 19, 2009
Last Verified: August 2009

Keywords provided by Sidney Kimmel Comprehensive Cancer Center:
Bone Marrow Transplant
Bone Mineral Density
Muscle Strength